Smart Nanosystems for Overcoming Multiple Biological Barriers in Cancer Nanomedicines Transport: Design Principles, Progress, and Challenges.

The development of smart nanosystems, which could overcome diverse biological barriers of nanomedicine transport, has received intense scientific interest in improving the therapeutic efficacies of traditional nanomedicines. However, the reported nanosystems generally hold disparate structures and functions, and the knowledge of involved biological barriers is usually scattered. There is an imperative need for a summary of biological barriers and how these smart nanosystems conquer biological barriers, to guide the rational design of the new-generation nanomedicines. This review starts from the discussion of major biological barriers existing in nanomedicine transport, including blood circulation, tumoral accumulation and penetration, cellular uptake, drug release, and response. Design principles and recent progress of smart nanosystems in overcoming the biological barriers are overviewed. The designated physicochemical properties of nanosystems can dictate their functions in biological environments, such as protein absorption inhibition, tumor accumulation, penetration, cellular internalization, endosomal escape, and controlled release, as well as modulation of tumor cells and their resident tumor microenvironment. The challenges facing smart nanosystems on the road heading to clinical approval are discussed, followed by the proposals that could further advance the nanomedicine field. It is expected that this review will provide guidelines for the rational design of the new-generation nanomedicines for clinical use.

[1]  J. Jokerst,et al.  Gold Nanorod-Melanin Hybrids for Enhanced and Prolonged Photoacoustic Imaging in the Near-Infrared-II Window. , 2021, ACS applied materials & interfaces.

[2]  Gan Lin,et al.  Gain an advantage from both sides: Smart size-shrinkable drug delivery nanosystems for high accumulation and deep penetration , 2021 .

[3]  Joseph J. Richardson,et al.  Polyphenol-Mediated Assembly for Particle Engineering. , 2020, Accounts of chemical research.

[4]  Qinghua Wu,et al.  Light-assisted hierarchical intratumoral penetration and programmed antitumor therapy based on tumor microenvironment (TME)-amendatory and self-adaptive polymeric nanoclusters. , 2020, Biomaterials.

[5]  Gang Zheng,et al.  Guidelines for the experimental design of pharmacokinetic studies with nanomaterials in preclinical animal models. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[6]  P. Mi Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics , 2020, Theranostics.

[7]  S. Wilhelm,et al.  The entry of nanoparticles into solid tumours , 2020, Nature Materials.

[8]  Xiaoyuan Chen,et al.  Metal-organic frameworks nanoswitch: Toward photo-controllable endo/lysosomal rupture and release for enhanced cancer RNA interference , 2020, Nano Research.

[9]  Batakrishna Jana,et al.  Cancer‐Targeted Nanomedicine: Overcoming the Barrier of the Protein Corona , 2020, Advanced Therapeutics.

[10]  Xuexiang Han,et al.  Emerging nanomedicines for anti-stromal therapy against desmoplastic tumors. , 2019, Biomaterials.

[11]  G. Zheng,et al.  Nanomedicines Lost in Translation. , 2019, ACS nano.

[12]  Fabian Kiessling,et al.  Smart cancer nanomedicine , 2019, Nature Nanotechnology.

[13]  Xiaodong Zhang,et al.  Construction of Dually Responsive Nanotransformers with Nanosphere-Nanofiber-Nanosphere Transition for Overcoming the Size Paradox of Anticancer Nanodrugs. , 2019, ACS nano.

[14]  T. Dvir,et al.  Collagenase Nanoparticles Enhance the Penetration of Drugs Into Pancreatic Tumors. , 2019, ACS nano.

[15]  K. Yarema,et al.  Exploiting metabolic glycoengineering to advance healthcare , 2019, Nature Reviews Chemistry.

[16]  S. Torp,et al.  Effect of Ultrasound on the Vasculature and Extravasation of Nanoscale Particles Imaged in Real Time. , 2019, Ultrasound in medicine & biology.

[17]  Z. Qian,et al.  Physical-, chemical-, and biological-responsive nanomedicine for cancer therapy. , 2019, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[18]  Min Liu,et al.  Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures. , 2019, Accounts of chemical research.

[19]  K. Kataoka,et al.  Ligand‐Installed Nanocarriers toward Precision Therapy , 2019, Advanced materials.

[20]  Zhihua Gan,et al.  Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy , 2019, Nature Nanotechnology.

[21]  Xianming Deng,et al.  Environmentally responsive dual-targeting nanotheranostics for overcoming cancer multidrug resistance. , 2019, Science bulletin.

[22]  F. Caruso,et al.  Selective Metal-Phenolic Assembly from Complex Multicomponent Mixtures. , 2019, ACS applied materials & interfaces.

[23]  S. Wilhelm,et al.  Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. , 2019, Advanced drug delivery reviews.

[24]  Peipei Xu,et al.  Overcoming Hypoxia by Multistage Nanoparticle Delivery System to Inhibit Mitochondrial Respiration for Photodynamic Therapy , 2019, Advanced Functional Materials.

[25]  Betty Y. S. Kim,et al.  Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery , 2019, Advanced science.

[26]  Wei Chen,et al.  Metal–Organic Framework‐Based Stimuli‐Responsive Systems for Drug Delivery , 2018, Advanced science.

[27]  Chunying Chen,et al.  The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine , 2018, Advanced materials.

[28]  Xiaoyuan Chen,et al.  Tumor Microenvironment-Responsive Ultrasmall Nanodrug Generators with Enhanced Tumor Delivery and Penetration. , 2018, Journal of the American Chemical Society.

[29]  Jin-Zhi Du,et al.  Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine. , 2018, Accounts of chemical research.

[30]  Edmund J. Crampin,et al.  Minimum information reporting in bio–nano experimental literature , 2018, Nature Nanotechnology.

[31]  Rui Tian,et al.  Hierarchical Tumor Microenvironment‐Responsive Nanomedicine for Programmed Delivery of Chemotherapeutics , 2018, Advanced materials.

[32]  Ding Ding,et al.  Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. , 2018, ACS nano.

[33]  X. Chu,et al.  Biomineralized Metal-Organic Framework Nanoparticles Enable Intracellular Delivery and Endo-Lysosomal Release of Native Active Proteins. , 2018, Journal of the American Chemical Society.

[34]  Xiaoyuan Chen,et al.  Stimuli-Responsive NO Release for On-Demand Gas-Sensitized Synergistic Cancer Therapy. , 2018, Angewandte Chemie.

[35]  R. Weichselbaum,et al.  Nanoscale Metal–Organic Frameworks for Therapeutic, Imaging, and Sensing Applications , 2018, Advanced materials.

[36]  K. Landfester,et al.  Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona , 2018, Nature Nanotechnology.

[37]  Dan Peer,et al.  Progress and challenges towards targeted delivery of cancer therapeutics , 2018, Nature Communications.

[38]  M. Gottesman,et al.  Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.

[39]  Zhen Gu,et al.  Advances in transformable drug delivery systems. , 2018, Biomaterials.

[40]  Weihong Zhu,et al.  Multifunctional Shell–Core Nanoparticles for Treatment of Multidrug Resistance Hepatocellular Carcinoma , 2018 .

[41]  Huile Gao,et al.  Influence of ligands property and particle size of gold nanoparticles on the protein adsorption and corresponding targeting ability. , 2018, International journal of pharmaceutics.

[42]  Paul Kumar Upputuri,et al.  Compact Plasmonic Blackbody for Cancer Theranosis in the Near-Infrared II Window. , 2018, ACS nano.

[43]  Gang Zheng,et al.  Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics. , 2018, Biomaterials.

[44]  Fajr A. Aleisa,et al.  Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework. , 2018, Journal of the American Chemical Society.

[45]  Qin Chen,et al.  Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics. , 2018, Trends in pharmacological sciences.

[46]  Z. Tian,et al.  pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells. , 2017, Biomaterials.

[47]  Jean-Christophe Leroux,et al.  Editorial: Drug Delivery: Too Much Complexity, Not Enough Reproducibility? , 2017, Angewandte Chemie.

[48]  Kwangmeyung Kim,et al.  Deep tissue penetration of nanoparticles using pulsed-high intensity focused ultrasound , 2017, Nano Convergence.

[49]  Ick Chan Kwon,et al.  Extracellular matrix remodeling in vivo for enhancing tumor‐targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[50]  Jong-Min Lim,et al.  Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics , 2017, Nature Communications.

[51]  Lanlan Liu,et al.  Cancer Cell Membrane‐Biomimetic Oxygen Nanocarrier for Breaking Hypoxia‐Induced Chemoresistance , 2017 .

[52]  T. Ji,et al.  Nanoparticle-mediated local depletion of tumour-associated platelets disrupts vascular barriers and augments drug accumulation in tumours , 2017, Nature Biomedical Engineering.

[53]  Jianjun Cheng,et al.  Sequentially Responsive Shell‐Stacked Nanoparticles for Deep Penetration into Solid Tumors , 2017, Advanced materials.

[54]  Xiaoyuan Chen,et al.  Tumor Microenvironment‐Triggered Supramolecular System as an In Situ Nanotheranostic Generator for Cancer Phototherapy , 2017, Advanced materials.

[55]  Miles A. Miller,et al.  Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts , 2017, Science Translational Medicine.

[56]  Leaf Huang,et al.  Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles. , 2017, ACS nano.

[57]  Yajun Wang,et al.  Near‐Infrared Laser‐Triggered Nitric Oxide Nanogenerators for the Reversal of Multidrug Resistance in Cancer , 2017 .

[58]  Youqing Shen,et al.  Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization , 2017, Advanced materials.

[59]  Xuesi Chen,et al.  Selective in vivo metabolic cell-labeling-mediated cancer targeting. , 2017, Nature chemical biology.

[60]  Naser Karimi,et al.  Application of Various Types of Liposomes in Drug Delivery Systems , 2017, Advanced pharmaceutical bulletin.

[61]  Morteza Mahmoudi,et al.  Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. , 2017, Trends in biotechnology.

[62]  Wen Jiang,et al.  Breaking Down the Barriers to Precision Cancer Nanomedicine. , 2017, Trends in biotechnology.

[63]  Dan Peer,et al.  Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. , 2017, ACS nano.

[64]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[65]  Liangzhu Feng,et al.  Liposomes co-loaded with metformin and chlorin e6 modulate tumor hypoxia during enhanced photodynamic therapy , 2017, Nano Research.

[66]  Huile Gao,et al.  Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation. , 2016, ACS nano.

[67]  Yingying Xu,et al.  Gd‐Hybridized Plasmonic Au‐Nanocomposites Enhanced Tumor‐Interior Drug Permeability in Multimodal Imaging‐Guided Therapy , 2016, Advanced materials.

[68]  Kai Yang,et al.  Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies. , 2016, Nano letters.

[69]  Xiaoyuan Chen,et al.  Hierarchical Targeting Strategy for Enhanced Tumor Tissue Accumulation/Retention and Cellular Internalization , 2016, Advanced materials.

[70]  M. Mahmoudi,et al.  Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors. , 2016, ACS applied materials & interfaces.

[71]  Hengte Ke,et al.  Rational Design of Multi-Stimuli-Responsive Nanoparticles for Precise Cancer Therapy. , 2016, ACS nano.

[72]  F. Kiessling,et al.  Sonoporation enhances liposome accumulation and penetration in tumors with low EPR. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[73]  Michael R Hamblin,et al.  Albumin nanostructures as advanced drug delivery systems , 2016, Expert opinion on drug delivery.

[74]  Zhen Gu,et al.  Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery , 2016 .

[75]  P. Mi,et al.  Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics , 2016, Advanced science.

[76]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[77]  Hao Cheng,et al.  Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy. , 2016, Nano letters.

[78]  Katharina Landfester,et al.  Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. , 2016, Nature nanotechnology.

[79]  Kam W. Leong,et al.  Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines , 2016 .

[80]  Jun Wang,et al.  Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy , 2016, Proceedings of the National Academy of Sciences.

[81]  Mingyuan Gao,et al.  In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics , 2016, Nature Communications.

[82]  Tianyue Jiang,et al.  Tumor Microenvironment-Mediated Construction and Deconstruction of Extracellular Drug-Delivery Depots. , 2016, Nano letters.

[83]  Yuliang Zhao,et al.  Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer‐Associated Fibroblast Activation , 2015, Angewandte Chemie.

[84]  Leaf Huang,et al.  Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[85]  Song Shen,et al.  Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery. , 2015, Journal of the American Chemical Society.

[86]  Kaikai Wang,et al.  Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy , 2015, Nature Communications.

[87]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[88]  Raimo Hartmann,et al.  Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake. , 2015, ACS nano.

[89]  M. Eblan,et al.  Clinical Translation of Nanomedicine. , 2015, Chemical reviews.

[90]  Kinam Park,et al.  Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities. , 2015, Chemical engineering science.

[91]  Jörg Huwyler,et al.  Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[92]  H. Ai,et al.  Delivery of siRNA by MRI-visible nanovehicles to overcome drug resistance in MCF-7/ADR human breast cancer cells. , 2014, Biomaterials.

[93]  Leone Spiccia,et al.  Zwitterionic-coated "stealth" nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system. , 2014, Small.

[94]  Bo Yan,et al.  Fabrication of Corona-Free Nanoparticles with Tunable Hydrophobicity , 2014, ACS nano.

[95]  Xiaomin Wang,et al.  Smart pH- and reduction-dual-responsive folate-PEG-coated polymeric lipid vesicles for tumor-triggered targeted drug delivery. , 2014, Nanoscale.

[96]  R. Leapman,et al.  Targeted Therapeutic Nanotubes Influence the Viscoelasticity of Cancer Cells to Overcome Drug Resistance , 2014, ACS nano.

[97]  R. Dacosta,et al.  Multifunctional albumin-MnO₂ nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response. , 2014, ACS nano.

[98]  Zhen Gu,et al.  Gel–Liposome‐Mediated Co‐Delivery of Anticancer Membrane‐Associated Proteins and Small‐Molecule Drugs for Enhanced Therapeutic Efficacy , 2014 .

[99]  Giulio Caracciolo,et al.  Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. , 2014, Nanoscale.

[100]  Y. Bae,et al.  Biodegradable cationic nanoparticles loaded with an anticancer drug for deep penetration of heterogeneous tumours. , 2013, Biomaterials.

[101]  Dieter Haemmerich,et al.  Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[102]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[103]  K. Greish,et al.  Anticancer nanomedicine and tumor vascular permeability; Where is the missing link? , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[104]  Kwangmeyung Kim,et al.  Bioorthogonal copper-free click chemistry in vivo for tumor-targeted delivery of nanoparticles. , 2012, Angewandte Chemie.

[105]  Lin Zhu,et al.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. , 2012, ACS nano.

[106]  R. Jain,et al.  Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner , 2012, Nature nanotechnology.

[107]  M. Uesaka,et al.  Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.

[108]  R. Gillies,et al.  Drug resistance and cellular adaptation to tumor acidic pH microenvironment. , 2011, Molecular pharmaceutics.

[109]  Ajit S Narang,et al.  Role of tumor vascular architecture in drug delivery. , 2011, Advanced drug delivery reviews.

[110]  Jesse V Jokerst,et al.  Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.

[111]  Neetu Singh,et al.  Nanoparticles that communicate in vivo to amplify tumour targeting. , 2011, Nature materials.

[112]  Gert Storm,et al.  Endosomal escape pathways for delivery of biologicals. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[113]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[114]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[115]  P. Choyke,et al.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.

[116]  Milan Makale,et al.  Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis , 2008, Proceedings of the National Academy of Sciences.

[117]  Milan Makale,et al.  Cellular mechanobiology and cancer metastasis. , 2007, Birth defects research. Part C, Embryo today : reviews.

[118]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[119]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[120]  A. Santoro,et al.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.